328 related articles for article (PubMed ID: 33494616)
1. Noncalcific Mechanisms of Bioprosthetic Structural Valve Degeneration.
Marro M; Kossar AP; Xue Y; Frasca A; Levy RJ; Ferrari G
J Am Heart Assoc; 2021 Feb; 10(3):e018921. PubMed ID: 33494616
[TBL] [Abstract][Full Text] [Related]
2. Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction.
Lee S; Levy RJ; Christian AJ; Hazen SL; Frick NE; Lai EK; Grau JB; Bavaria JE; Ferrari G
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28483776
[TBL] [Abstract][Full Text] [Related]
3. Aortic Bioprosthetic Valve Durability: Incidence, Mechanisms, Predictors, and Management of Surgical and Transcatheter Valve Degeneration.
Rodriguez-Gabella T; Voisine P; Puri R; Pibarot P; Rodés-Cabau J
J Am Coll Cardiol; 2017 Aug; 70(8):1013-1028. PubMed ID: 28818190
[TBL] [Abstract][Full Text] [Related]
4. Degeneration of Bioprosthetic Heart Valves: Update 2020.
Kostyunin AE; Yuzhalin AE; Rezvova MA; Ovcharenko EA; Glushkova TV; Kutikhin AG
J Am Heart Assoc; 2020 Oct; 9(19):e018506. PubMed ID: 32954917
[TBL] [Abstract][Full Text] [Related]
5. Modes of bioprosthetic valve failure: a narrative review.
Koziarz A; Makhdoum A; Butany J; Ouzounian M; Chung J
Curr Opin Cardiol; 2020 Mar; 35(2):123-132. PubMed ID: 31972604
[TBL] [Abstract][Full Text] [Related]
6. Radical polymerization-crosslinking method for improving extracellular matrix stability in bioprosthetic heart valves with reduced potential for calcification and inflammatory response.
Guo G; Jin L; Jin W; Chen L; Lei Y; Wang Y
Acta Biomater; 2018 Dec; 82():44-55. PubMed ID: 30326277
[TBL] [Abstract][Full Text] [Related]
7. Age-related enhanced degeneration of bioprosthetic valves due to leaflet calcification, tissue crosslinking, and structural changes.
Xue Y; Kossar AP; Abramov A; Frasca A; Sun M; Zyablitskaya M; Paik D; Kalfa D; Della Barbera M; Thiene G; Kozaki S; Kawashima T; Gorman JH; Gorman RC; Gillespie MJ; Carreon CK; Sanders SP; Levy RJ; Ferrari G
Cardiovasc Res; 2023 Mar; 119(1):302-315. PubMed ID: 35020813
[TBL] [Abstract][Full Text] [Related]
8. Porcine bioprosthetic heart valves: The next generation.
Manji RA; Menkis AH; Ekser B; Cooper DK
Am Heart J; 2012 Aug; 164(2):177-85. PubMed ID: 22877802
[TBL] [Abstract][Full Text] [Related]
9. How to Decide Between a Bioprosthetic and Mechanical Valve.
David T
Can J Cardiol; 2021 Jul; 37(7):1121-1123. PubMed ID: 33002585
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Long-Term Structural Deterioration of Transcatheter Aortic Bioprosthetic Valves Using the New European Definition.
Durand E; Sokoloff A; Urena-Alcazar M; Chevalier B; Chassaing S; Didier R; Tron C; Litzler PY; Bouleti C; Himbert D; Hovasse T; Bar O; Avinée G; Iung B; Blanchard D; Gilard M; Cribier A; Lefevre T; Eltchaninoff H
Circ Cardiovasc Interv; 2019 Apr; 12(4):e007597. PubMed ID: 30998397
[TBL] [Abstract][Full Text] [Related]
11. Bioprosthetic aortic valve durability in the era of transcatheter aortic valve implantation.
Salaun E; Clavel MA; Rodés-Cabau J; Pibarot P
Heart; 2018 Aug; 104(16):1323-1332. PubMed ID: 29735584
[TBL] [Abstract][Full Text] [Related]
12. Incidence, risk factors, clinical impact, and management of bioprosthesis structural valve degeneration.
Côté N; Pibarot P; Clavel MA
Curr Opin Cardiol; 2017 Mar; 32(2):123-129. PubMed ID: 28067715
[TBL] [Abstract][Full Text] [Related]
13. Pathology of substitute heart valves: new concepts and developments.
Schoen FJ; Levy RJ
J Card Surg; 1994 Mar; 9(2 Suppl):222-7. PubMed ID: 8186572
[TBL] [Abstract][Full Text] [Related]
14. Glycation and Serum Albumin Infiltration Contribute to the Structural Degeneration of Bioprosthetic Heart Valves.
Frasca A; Xue Y; Kossar AP; Keeney S; Rock C; Zakharchenko A; Streeter M; Gorman RC; Grau JB; George I; Bavaria JE; Krieger A; Spiegel DA; Levy RJ; Ferrari G
JACC Basic Transl Sci; 2020 Aug; 5(8):755-766. PubMed ID: 32875167
[TBL] [Abstract][Full Text] [Related]
15. Proteolytic Degradation Is a Major Contributor to Bioprosthetic Heart Valve Failure.
Kostyunin AE; Glushkova TV; Lobov AA; Ovcharenko EA; Zainullina BR; Bogdanov LA; Shishkova DK; Markova VE; Asanov MA; Mukhamadiyarov RA; Velikanova EA; Akentyeva TN; Rezvova MA; Stasev AN; Evtushenko AV; Barbarash LS; Kutikhin AG
J Am Heart Assoc; 2023 Jan; 12(1):e028215. PubMed ID: 36565196
[TBL] [Abstract][Full Text] [Related]
16. Early Leaflet Thickening, Durability and Bioprosthetic Valve Failure in TAVR.
Case BC; Khan JM; Rogers T
Interv Cardiol Clin; 2021 Oct; 10(4):531-539. PubMed ID: 34593115
[TBL] [Abstract][Full Text] [Related]
17. A versatile modification strategy for functional non-glutaraldehyde cross-linked bioprosthetic heart valves with enhanced anticoagulant, anticalcification and endothelialization properties.
Yu T; Pu H; Chen X; Kong Q; Chen C; Li G; Jiang Q; Wang Y
Acta Biomater; 2023 Apr; 160():45-58. PubMed ID: 36764592
[TBL] [Abstract][Full Text] [Related]
18. [Surgical pathology analysis of the causes of failure of 48 bioprosthetic heart valves in 40 Chinese cases].
Duan XJ; Wang HY; Xu JP; Li L; Xu HY; Wang QZ
Zhonghua Wai Ke Za Zhi; 2016 Sep; 54(9):710-5. PubMed ID: 27587216
[TBL] [Abstract][Full Text] [Related]
19. A universal strategy for the construction of polymer brush hybrid non-glutaraldehyde heart valves with robust anti-biological contamination performance and improved endothelialization potential.
Yu T; Zheng C; Chen X; Pu H; Li G; Jiang Q; Wang Y; Guo Y
Acta Biomater; 2023 Apr; 160():87-97. PubMed ID: 36812953
[TBL] [Abstract][Full Text] [Related]
20. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study.
Chakravarty T; Søndergaard L; Friedman J; De Backer O; Berman D; Kofoed KF; Jilaihawi H; Shiota T; Abramowitz Y; Jørgensen TH; Rami T; Israr S; Fontana G; de Knegt M; Fuchs A; Lyden P; Trento A; Bhatt DL; Leon MB; Makkar RR; ;
Lancet; 2017 Jun; 389(10087):2383-2392. PubMed ID: 28330690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
